VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 560 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2015. The put-call ratio across all filers is 2.18 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $444,000 | +11.8% | 2,000 | 0.0% | 0.13% | +15.5% |
| Q1 2015 | $397,000 | +38.8% | 2,000 | 0.0% | 0.12% | +41.5% |
| Q4 2014 | $286,000 | +9.2% | 2,000 | 0.0% | 0.08% | +9.3% |
| Q3 2014 | $262,000 | +4.0% | 2,000 | 0.0% | 0.08% | +1.4% |
| Q2 2014 | $252,000 | +18.3% | 2,000 | -4.8% | 0.07% | +131.2% |
| Q3 2013 | $213,000 | -99.9% | 2,100 | -47.5% | 0.03% | -63.6% |
| Q2 2013 | $172,332,000 | – | 4,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |